Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Acta Clinica Belgica
|
January 1, 1983
Acute leukaemia following prolonged chlorambucil treatment for non-neoplastic disease - a study of two cases and literature review
J P Aymard, P Lederlin, F Witz, et al.
Blood
|
November 14, 1997
Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome
H Tilly, P Gaulard, E Lepage, et al.
Cancer
|
May 20, 1998
A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'Adulte
N Mounier, P Morel, C Haioun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1996
Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'Adulte
A Guerci, P Lederlin, F Reyes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2000
Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lymphomes de l'Adulte
C Haioun, C Besson, E Lepage, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte
H Tilly, N Mounier, P Lederlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 18, 2003
Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab
P Feugier, J M Virion, H Tilly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte
M Diviné, E Lepage, J Brière, et al.
Oncology Reports
|
October 14, 1998
Treatment of subdiaphragmatic Hodgkin's disease: long-term results and side effects
B Cutuli, T Petit, S Hoffstetter, et al.
Blood
|
March 25, 2000
Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trial
C Fermé, C Sebban, C Hennequin, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Acta Clinica Belgica
|
January 1, 1983
Acute leukaemia following prolonged chlorambucil treatment for non-neoplastic disease - a study of two cases and literature review
J P Aymard, P Lederlin, F Witz, et al.
Blood
|
November 14, 1997
Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome
H Tilly, P Gaulard, E Lepage, et al.
Cancer
|
May 20, 1998
A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'Adulte
N Mounier, P Morel, C Haioun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1996
Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'Adulte
A Guerci, P Lederlin, F Reyes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2000
Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lymphomes de l'Adulte
C Haioun, C Besson, E Lepage, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte
H Tilly, N Mounier, P Lederlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 18, 2003
Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab
P Feugier, J M Virion, H Tilly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte
M Diviné, E Lepage, J Brière, et al.
Oncology Reports
|
October 14, 1998
Treatment of subdiaphragmatic Hodgkin's disease: long-term results and side effects
B Cutuli, T Petit, S Hoffstetter, et al.
Blood
|
March 25, 2000
Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trial
C Fermé, C Sebban, C Hennequin, et al.
Page
of 8